Entity Details

Primary name GLRX5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ86SX6
EntryNameGLRX5_HUMAN
FullNameGlutaredoxin-related protein 5, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length157
SequenceStatuscomplete
DateCreated2005-02-01
DateModified2021-06-02

Ontological Relatives

GenesGLRX5

GO terms

Show/Hide Table
GOName
GO:0005634 nucleus
GO:0005739 mitochondrion
GO:0005759 mitochondrial matrix
GO:0015035 protein-disulfide reductase activity
GO:0016226 iron-sulfur cluster assembly
GO:0030097 hemopoiesis
GO:0030425 dendrite
GO:0043025 neuronal cell body
GO:0044571 [2Fe-2S] cluster assembly
GO:0046872 metal ion binding
GO:0051537 2 iron, 2 sulfur cluster binding
GO:0106034 protein maturation by [2Fe-2S] cluster transfer
GO:0106035 protein maturation by [4Fe-4S] cluster transfer

Subcellular Location

Show/Hide Table
Subcellular Location
Mitochondrion matrix

Domains

Show/Hide Table
DomainNameCategoryType
IPR002109 GlutaredoxinDomainDomain
IPR004480 Monothiol glutaredoxin-relatedFamilyFamily
IPR033658 Glutaredoxin, PICOT-likeDomainDomain
IPR036249 Thioredoxin-like superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
616859 OMIMSpasticity, childhood-onset, with hyperglycinemia (SPAHGC)An autosomal recessive disorder characterized by childhood-onset of spasticity, spinal lesions, leukodystrophy, optic atrophy in some patients, non-ketotic hyperglycinemia, and defective enzymatic glycine cleavage. Glycine levels in the cerebrospinal fluid are mildly increased in some but not all patients. The increase is less pronounced than in patients with classic non-ketotic hyperglycinemia. The disease is caused by variants affecting the gene represented in this entry.
616860 OMIMAnemia, sideroblastic, 3, pyridoxine-refractory (SIDBA3)A form of sideroblastic anemia, a bone marrow disorder defined by the presence of pathologic iron deposits in erythroblast mitochondria. Sideroblastic anemia is characterized by anemia of varying severity, hypochromic peripheral erythrocytes, systemic iron overload secondary to chronic ineffective erythropoiesis, and the presence of bone marrow ringed sideroblasts. Sideroblasts are characterized by iron-loaded mitochondria clustered around the nucleus. SIDBA3 is refractory to treatment with vitamin B6, while iron chelation therapy may result in clinical improvement. SIDBA3 inheritance is autosomal recessive. The disease is caused by variants affecting the gene represented in this entry.